Beam Therapeutics Inc.
BEAM
$26.75
$0.240.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.07% | -138.61% | 316.71% | -10.37% | 5.72% |
| Total Depreciation and Amortization | -3.48% | -1.11% | 1.94% | 0.40% | 0.18% |
| Total Amortization of Deferred Charges | 82.86% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.03% | 106.82% | -805.19% | 96.37% | -31.49% |
| Change in Net Operating Assets | 150.74% | 45.40% | -1,329.81% | -307.09% | 113.51% |
| Cash from Operations | 48.57% | -54.30% | -2.22% | -6.58% | 26.41% |
| Capital Expenditure | -8.15% | 40.22% | 25.48% | -59.79% | -2.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -127.13% | -75.48% | 58.52% | 142.29% | -37.08% |
| Cash from Investing | -139.08% | -76.69% | 65.12% | 138.53% | -36.23% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 112.81% | 87.43% | 12.60% | 51.04% | -99.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -92.21% | 5,022.38% | 12.60% | 51.04% | -99.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -931.46% | -124.57% | 290.85% | 94.24% | -200.55% |